Comparison of 2 Sets of Immunoassays Used in Modified 2-Tiered Testing Algorithms for the Diagnosis of Lyme Disease
The Journal of Applied Laboratory Medicine · 2025
DOI: 10.1093/jalm/jfae127 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift The Journal of Applied Laboratory Medicine, 2025. Verfasst von Michael E Walsh und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Laboratory Medicine, Dartmouth-Hitchcock Medical Center, Lebanon, NH, United States. Hauptthemen laut MEDLINE: Lyme Disease, Algorithms, Antibodies, Bacterial, Borrelia burgdorferi. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 24 Literaturangaben.
Abstract (Originalsprache)
Background
Since 2019, modified 2-tiered testing (MTTT) algorithms have been available for the diagnosis of Lyme disease. MTTTs replaced the standard algorithms that utilized enzyme immunoassays and immunoblots with sequential enzyme immunoassays that detect different antigens.
Methods
We compared the performance of serological assays from ZEUS Scientific Inc. and DiaSorin Inc. that are used for the diagnosis of Lyme disease. Serological results were compared with clinical information gathered by chart review.
Results
Percent positive agreement (PPA) and percent negative agreement (PNA) for total immunoglobulin G (IgG)/immunoglogulin M (IgM) (n = 120) were 64% (95% confidence interval 54% to 73%) and 100% (87% to 100%), respectively. PPA and PNA for IgG (n = 93) were 91% (80% to 97%) and 66% (52% to 78%), respectively. PPA and PNA for IgM (n = 93) were 75% (62% to 85%) and 95% (82% to 99%), respectively. Fewer positive total IgG/IgM results confirmed positive for either IgG or IgM for ZEUS compared to DiaSorin. Overall MTTT algorithm interpretation was concordant in 58% (55/95) of samples, and concordance improved when the results were limited to IgM in patients with symptom duration <30 days. Treatment with antibiotics was most strongly associated with IgM positivity.
Conclusions
This analysis highlights differences in the performance characteristics between commercially available diagnostic assays for Lyme disease. Our data suggest that the DiaSorin assays would result in fewer positive total IgG/IgM tests, decreasing the required number of confirmatory IgG and IgM tests. This would potentially lead to fewer patients treated with antibiotics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pathology and Laboratory Medicine, Dartmouth-Hitchcock Medical Center, Lebanon, NH, United States.
- The Geisel School of Medicine at Dartmouth, Hanover, NH, United States.
ORCID-Profile: Michael E Walsh, Isabella W Martin
Zitieren
APA
Walsh, M. E., Sietsma, D. J., Martin, I. W., & Brunelle, L. A. (2025). Comparison of 2 Sets of Immunoassays Used in Modified 2-Tiered Testing Algorithms for the Diagnosis of Lyme Disease. The Journal of Applied Laboratory Medicine. https://doi.org/10.1093/jalm/jfae127
Vancouver
Walsh ME, Sietsma DJ, Martin IW, Brunelle LA. Comparison of 2 Sets of Immunoassays Used in Modified 2-Tiered Testing Algorithms for the Diagnosis of Lyme Disease. The Journal of Applied Laboratory Medicine. 2025. doi:10.1093/jalm/jfae127
BibTeX
@article{Walsh2025,
author = {Walsh, Michael E and Sietsma, Daniel J and Martin, Isabella W and Brunelle, Lynn A},
title = {Comparison of 2 Sets of Immunoassays Used in Modified 2-Tiered Testing Algorithms for the Diagnosis of Lyme Disease},
journal = {The Journal of Applied Laboratory Medicine},
year = {2025},
doi = {10.1093/jalm/jfae127}
}
EUVIMED